Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Vaccine

Topics

Biology

Biochemistry

Physics

Medicine

Immunology

Show all topics

DOI

10.1016/j.vaccine.2024.126685

License

CC-BY-NC-ND